Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
XRAY's Cash to Debt is ranked lower than
54% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. XRAY: 0.04 )
XRAY' s 10-Year Cash to Debt Range
Min: 0.02   Max: 1.01
Current: 0.04

0.02
1.01
Equity to Asset 0.50
XRAY's Equity to Asset is ranked higher than
61% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. XRAY: 0.50 )
XRAY' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.63
Current: 0.5

0.34
0.63
Interest Coverage 8.45
XRAY's Interest Coverage is ranked higher than
59% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. XRAY: 8.45 )
XRAY' s 10-Year Interest Coverage Range
Min: 4.1   Max: 29.14
Current: 8.45

4.1
29.14
F-Score: 7
Z-Score: 3.26
M-Score: -2.54
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.21
XRAY's Operating margin (%) is ranked higher than
83% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. XRAY: 14.21 )
XRAY' s 10-Year Operating margin (%) Range
Min: 4.25   Max: 18.42
Current: 14.21

4.25
18.42
Net-margin (%) 10.61
XRAY's Net-margin (%) is ranked higher than
82% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.08 vs. XRAY: 10.61 )
XRAY' s 10-Year Net-margin (%) Range
Min: 2.65   Max: 14.94
Current: 10.61

2.65
14.94
ROE (%) 12.35
XRAY's ROE (%) is ranked higher than
84% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. XRAY: 12.35 )
XRAY' s 10-Year ROE (%) Range
Min: 3.64   Max: 19.93
Current: 12.35

3.64
19.93
ROA (%) 6.17
XRAY's ROA (%) is ranked higher than
79% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. XRAY: 6.17 )
XRAY' s 10-Year ROA (%) Range
Min: 1.88   Max: 11.66
Current: 6.17

1.88
11.66
ROC (Joel Greenblatt) (%) 34.37
XRAY's ROC (Joel Greenblatt) (%) is ranked higher than
86% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.70 vs. XRAY: 34.37 )
XRAY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.51   Max: 54.89
Current: 34.37

12.51
54.89
Revenue Growth (%) 10.20
XRAY's Revenue Growth (%) is ranked higher than
82% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. XRAY: 10.20 )
XRAY' s 10-Year Revenue Growth (%) Range
Min: 3.8   Max: 21.5
Current: 10.2

3.8
21.5
EBITDA Growth (%) 7.10
XRAY's EBITDA Growth (%) is ranked higher than
74% of the 230 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. XRAY: 7.10 )
XRAY' s 10-Year EBITDA Growth (%) Range
Min: -22.4   Max: 50.5
Current: 7.1

-22.4
50.5
EPS Growth (%) 5.90
XRAY's EPS Growth (%) is ranked higher than
73% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. XRAY: 5.90 )
XRAY' s 10-Year EPS Growth (%) Range
Min: -32.7   Max: 88.3
Current: 5.9

-32.7
88.3
» XRAY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

XRAY Guru Trades in Q2 2013

Jim Simons 208,258 sh (New)
Jeremy Grantham 23,800 sh (+59.73%)
Vanguard Health Care Fund 2,285,400 sh (unchged)
Robert Olstein 144,000 sh (unchged)
Columbia Wanger Sold Out
John Keeley Sold Out
Steven Cohen Sold Out
Mario Gabelli 205,940 sh (-2.14%)
Meridian Funds 1,012,000 sh (-4.71%)
» More
Q3 2013

XRAY Guru Trades in Q3 2013

Steven Cohen 14,554 sh (New)
Chuck Royce 96,518 sh (New)
Jeremy Grantham 25,400 sh (+6.72%)
Vanguard Health Care Fund 2,285,400 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 203,640 sh (-1.12%)
Robert Olstein 138,000 sh (-4.17%)
» More
Q4 2013

XRAY Guru Trades in Q4 2013

Paul Tudor Jones 17,872 sh (New)
Chuck Royce 250,318 sh (+159.35%)
Vanguard Health Care Fund 2,826,100 sh (+23.66%)
Mario Gabelli 201,040 sh (-1.28%)
Jeremy Grantham 24,100 sh (-5.12%)
Robert Olstein 113,000 sh (-18.12%)
Steven Cohen 5,503 sh (-62.19%)
» More
Q1 2014

XRAY Guru Trades in Q1 2014

Jim Simons 729,258 sh (New)
Chuck Royce 252,318 sh (+0.8%)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Robert Olstein 113,000 sh (unchged)
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Mario Gabelli 189,740 sh (-5.62%)
Paul Tudor Jones 12,959 sh (-27.49%)
» More
» Details

Insider Trades

Latest Guru Trades with XRAY

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2013-12-31 Add 23.66%0.08%$43.22 - $48.86 $ 46.890%2826100
John Keeley 2013-06-30 Sold Out 0.03%$40.24 - $44.2 $ 46.8912%0
Joel Greenblatt 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 46.8912%0
Tom Gayner 2013-03-31 Sold Out 0.06%$39.59 - $43.49 $ 46.8912%0
Joel Greenblatt 2012-12-31 New Buy0.06%$36.17 - $40.5 $ 46.8921%24660
John Keeley 2012-03-31 Add 28.9%0.01%$35.02 - $40.19 $ 46.8931%41440
Ray Dalio 2011-12-31 Sold Out 0.25%$29.09 - $38.82 $ 46.8936%0
Jean-Marie Eveillard 2011-12-31 Sold Out 0.01%$29.09 - $38.82 $ 46.8936%0
Ray Dalio 2011-09-30 New Buy0.25%$30.86 - $39.555 $ 46.8933%550695
Meridian Funds 2011-09-30 Add 6.86%0.11%$30.86 - $39.555 $ 46.8933%1475476
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.50
XRAY's P/E(ttm) is ranked higher than
87% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. XRAY: 21.50 )
XRAY' s 10-Year P/E(ttm) Range
Min: 12.19   Max: 116
Current: 21.5

12.19
116
P/B 2.60
XRAY's P/B is ranked higher than
75% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. XRAY: 2.60 )
XRAY' s 10-Year P/B Range
Min: 2.07   Max: 4.65
Current: 2.6

2.07
4.65
P/S 2.30
XRAY's P/S is ranked higher than
76% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. XRAY: 2.30 )
XRAY' s 10-Year P/S Range
Min: 1.58   Max: 3.59
Current: 2.3

1.58
3.59
PFCF 19.60
XRAY's PFCF is ranked higher than
90% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 81.48 vs. XRAY: 19.60 )
XRAY' s 10-Year PFCF Range
Min: 12.39   Max: 28.2
Current: 19.6

12.39
28.2
EV-to-EBIT 18.50
XRAY's EV-to-EBIT is ranked higher than
82% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. XRAY: 18.50 )
XRAY' s 10-Year EV-to-EBIT Range
Min: 9.8   Max: 71.7
Current: 18.5

9.8
71.7
PEG 3.40
XRAY's PEG is ranked higher than
84% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.00 vs. XRAY: 3.40 )
XRAY' s 10-Year PEG Range
Min: 0.58   Max: 80.69
Current: 3.4

0.58
80.69
Shiller P/E 22.70
XRAY's Shiller P/E is ranked higher than
93% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 22.70 )
XRAY' s 10-Year Shiller P/E Range
Min: 16.04   Max: 37.32
Current: 22.7

16.04
37.32
Current Ratio 1.24
XRAY's Current Ratio is ranked higher than
51% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. XRAY: 1.24 )
XRAY' s 10-Year Current Ratio Range
Min: 1.2   Max: 3.9
Current: 1.24

1.2
3.9
Quick Ratio 0.77
XRAY's Quick Ratio is ranked higher than
50% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. XRAY: 0.77 )
XRAY' s 10-Year Quick Ratio Range
Min: 0.76   Max: 2.98
Current: 0.77

0.76
2.98

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.60
XRAY's Dividend Yield is ranked lower than
80% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. XRAY: 0.60 )
XRAY' s 10-Year Dividend Yield Range
Min: 0.35   Max: 0.85
Current: 0.6

0.35
0.85
Dividend Payout 0.12
XRAY's Dividend Payout is ranked higher than
98% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 0.12 )
XRAY' s 10-Year Dividend Payout Range
Min: 0.05   Max: 5.67
Current: 0.12

0.05
5.67
Dividend growth (3y) 7.70
XRAY's Dividend growth (3y) is ranked higher than
75% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. XRAY: 7.70 )
XRAY' s 10-Year Dividend growth (3y) Range
Min: 3.2   Max: 14.8
Current: 7.7

3.2
14.8
Yield on cost (5-Year) 0.79
XRAY's Yield on cost (5-Year) is ranked lower than
68% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.47 vs. XRAY: 0.79 )
XRAY' s 10-Year Yield on cost (5-Year) Range
Min: 0.46   Max: 1.12
Current: 0.79

0.46
1.12
Share Buyback Rate 0.20
XRAY's Share Buyback Rate is ranked higher than
87% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. XRAY: 0.20 )
XRAY' s 10-Year Share Buyback Rate Range
Min: 2.2   Max: -1.3
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.20
XRAY's Price/DCF (Projected) is ranked higher than
92% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.59 vs. XRAY: 1.20 )
XRAY' s 10-Year Price/DCF (Projected) Range
Min: 0.99   Max: 2.39
Current: 1.2

0.99
2.39
Price/Median PS Value 1.00
XRAY's Price/Median PS Value is ranked higher than
82% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. XRAY: 1.00 )
XRAY' s 10-Year Price/Median PS Value Range
Min: 0.61   Max: 1.46
Current: 1

0.61
1.46
Price/Peter Lynch Fair Value 3.60
XRAY's Price/Peter Lynch Fair Value is ranked higher than
87% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. XRAY: 3.60 )
XRAY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65   Max: 11.61
Current: 3.6

0.65
11.61
Earnings Yield (Greenblatt) 5.30
XRAY's Earnings Yield (Greenblatt) is ranked higher than
72% of the 252 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. XRAY: 5.30 )
XRAY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 10.2
Current: 5.3

1.4
10.2
Forward Rate of Return (Yacktman) 9.63
XRAY's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 257 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.95 vs. XRAY: 9.63 )
XRAY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.3   Max: 32.8
Current: 9.63

-5.3
32.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:DY2.Germany
DENTSPLY International, Inc., was incorporated in 1899 in Delaware. The Company is a designer, developer, manufacturer and marketer of a range of consumable dental products for the professional dental market. The Company also manufactures and markets other consumable medical device products. The Company's main product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company conducted its business through four operating segments. All of the Company's segments are mainly engaged in the design, manufacture and distribution of dental and medical products in four principal product categories: dental consumable products; dental laboratory products; dental specialty products; and consumable medical device products. Dental consumable products consist of dental sundries and small equipment used in dental offices for the treatment of patients. The Company's dental sundry products in the dental consumable products category include dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners and topical fluoride. Dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company's products in the dental laboratory products category include dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics and crown and bridge materials. Dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company's products in this category include endodontic (root canal) instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, dental lasers and orthodontic appliances and accessories. Consumable medical device products consist mainly of urological products including catheters, certain surgical products, medical drills and other non-medical products. The Company conducts its business in the United States of America ('U.S.'), as well as in over 120 foreign countries, principally through its foreign subsidiaries. DENTSPLY has a long-established presence in the European market, particularly in Germany, Sweden, Switzerland, France, Italy and the United Kingdom as well as in Canada. The Company also has market presence in the countries of the Commonwealth of Independent States ('CIS'), Central and South America and the Pacific Rim. The Company's products are subject to regulation by, among other governmental entities, the U.S. Food and Drug Administration.
» More Articles for XRAY

Headlines

Articles On GuruFocus.com
Global for Resilience – Columbia Management Selling Update Aug 29 2013 
4stars, lots of buys Dec 21 2011 
New Guru Added: Ray Dalio of Bridgewater Associates Dec 02 2011 
DENTSPLY International Inc. Reports Operating Results (10-K) Feb 18 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Tom Gayner Top Buys: ITC Holdings Corp., Patterson Companies Inc., Schlumberger Ltd., Walgreen Compa Nov 09 2009 
Richard Aster Jr Buys Zebra Technologies Corp., Bunge Ltd., Liz Claiborne Inc., Sells Time Warner In Nov 03 2006 

More From Other Websites
DENTSPLY International Schedules Second Quarter Fiscal 2014 Earnings Release and Conference Call Jul 17 2014
DENTSPLY International Inc. to Present at the William Blair 34th Annual Growth Stock Conference Jun 10 2014
DENTSPLY International Inc. to Present at the Jefferies 2014 Global Healthcare Conference Jun 02 2014
DENTSPLY International Inc. to Present at the Stifel 2014 Dental & Veterinary Conference May 27 2014
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security... May 22 2014
DENTSPLY International Inc. Declares Cash Dividend May 22 2014
Dentsply upgraded to Outperform from Market Perform at Barrington May 16 2014
DENTSPLY INTERNATIONAL INC /DE/ Financials May 14 2014
DENTSPLY International Inc. to Present at the Bank of America Merrill Lynch 2014 Healthcare... May 12 2014
DENTSPLY International's (XRAY) CEO Bret Wise on Q1 2014 Results - Earnings Call Transcript May 06 2014
DENTSPLY (XRAY) Beats on Q1 Earnings May 06 2014
Dentsply International Inc Earnings Call scheduled for 8:30 am ET today May 06 2014
Q1 2014 Dentsply International Earnings Conference Call (XRAY) Q1 2014 Results - Earnings Call... May 06 2014
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2014
Q1 2014 Dentsply International Inc Earnings Release - Before Market Open May 06 2014
DENTSPLY International Reports First Quarter 2014 Results May 06 2014
Can DENTSPLY (XRAY) Surprise This Earnings Season? May 01 2014
DENTSPLY International Schedules First Quarter Fiscal 2014 Earnings Release and Conference Call Apr 15 2014
[video] Currency crush: Managing currency risk in EM Apr 02 2014
DENTSPLY International Raised to Hold Mar 11 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide